Profilassi del danno da FANS

Translated title of the contribution: Prophylaxis of intestinal damages caused by NSAIDs

Marco Lazzaroni, Valentine Casini, Elisa Ferrara, Gabriele Bianchi Porro

Research output: Contribution to journalArticle

Abstract

While the most effective strategy to prevent non-steroidal anti-inflammatory drugs (NSAIDs) related gastrointestinal lesions, is to not prescribe them, this option is often impractical. The use of specific agents to prevent NSAIDs toxicity has focused upon two approaches: replacement of prostaglandin deficiency and inhibition of acid secretion. H2 blockers significantly reduce duodenal ulcer rates, but are ineffective in preventing gastric ulceration. In long term prevention studies, proton pump inhibitors have been shown to reduce the risk of gastric and duodenal ulcers and NSAID-related dyspepsia. Recent comparative studies of PPIs versus H2 antagonists and misoprostol showed that, after 6-12 months of follow up, the proton pump inhibitors were significantly superior to control drugs in reducing the risk both of gastric and duodenal ulcer.

Original languageItalian
Pages (from-to)39-45
Number of pages7
JournalArgomenti di Gastroenterologia Clinica
Volume18
Issue number1
Publication statusPublished - Jun 2005

Fingerprint

Duodenal Ulcer
Anti-Inflammatory Agents
Proton Pump Inhibitors
Stomach Ulcer
Pharmaceutical Preparations
Gastrointestinal Agents
Misoprostol
Dyspepsia
Drug and Narcotic Control
Drug-Related Side Effects and Adverse Reactions
Prostaglandins
Stomach
Acids

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Lazzaroni, M., Casini, V., Ferrara, E., & Bianchi Porro, G. (2005). Profilassi del danno da FANS. Argomenti di Gastroenterologia Clinica, 18(1), 39-45.

Profilassi del danno da FANS. / Lazzaroni, Marco; Casini, Valentine; Ferrara, Elisa; Bianchi Porro, Gabriele.

In: Argomenti di Gastroenterologia Clinica, Vol. 18, No. 1, 06.2005, p. 39-45.

Research output: Contribution to journalArticle

Lazzaroni, M, Casini, V, Ferrara, E & Bianchi Porro, G 2005, 'Profilassi del danno da FANS', Argomenti di Gastroenterologia Clinica, vol. 18, no. 1, pp. 39-45.
Lazzaroni M, Casini V, Ferrara E, Bianchi Porro G. Profilassi del danno da FANS. Argomenti di Gastroenterologia Clinica. 2005 Jun;18(1):39-45.
Lazzaroni, Marco ; Casini, Valentine ; Ferrara, Elisa ; Bianchi Porro, Gabriele. / Profilassi del danno da FANS. In: Argomenti di Gastroenterologia Clinica. 2005 ; Vol. 18, No. 1. pp. 39-45.
@article{e6348bb454e34469bdb513066788fd7b,
title = "Profilassi del danno da FANS",
abstract = "While the most effective strategy to prevent non-steroidal anti-inflammatory drugs (NSAIDs) related gastrointestinal lesions, is to not prescribe them, this option is often impractical. The use of specific agents to prevent NSAIDs toxicity has focused upon two approaches: replacement of prostaglandin deficiency and inhibition of acid secretion. H2 blockers significantly reduce duodenal ulcer rates, but are ineffective in preventing gastric ulceration. In long term prevention studies, proton pump inhibitors have been shown to reduce the risk of gastric and duodenal ulcers and NSAID-related dyspepsia. Recent comparative studies of PPIs versus H2 antagonists and misoprostol showed that, after 6-12 months of follow up, the proton pump inhibitors were significantly superior to control drugs in reducing the risk both of gastric and duodenal ulcer.",
keywords = "Gastro-duodenal ulcer, H2 antagonists, Misoprostol, NSAIDs, Proton pump inhibitors",
author = "Marco Lazzaroni and Valentine Casini and Elisa Ferrara and {Bianchi Porro}, Gabriele",
year = "2005",
month = "6",
language = "Italian",
volume = "18",
pages = "39--45",
journal = "Argomenti di Gastroenterologia Clinica",
issn = "1120-8651",
publisher = "Masson SpA",
number = "1",

}

TY - JOUR

T1 - Profilassi del danno da FANS

AU - Lazzaroni, Marco

AU - Casini, Valentine

AU - Ferrara, Elisa

AU - Bianchi Porro, Gabriele

PY - 2005/6

Y1 - 2005/6

N2 - While the most effective strategy to prevent non-steroidal anti-inflammatory drugs (NSAIDs) related gastrointestinal lesions, is to not prescribe them, this option is often impractical. The use of specific agents to prevent NSAIDs toxicity has focused upon two approaches: replacement of prostaglandin deficiency and inhibition of acid secretion. H2 blockers significantly reduce duodenal ulcer rates, but are ineffective in preventing gastric ulceration. In long term prevention studies, proton pump inhibitors have been shown to reduce the risk of gastric and duodenal ulcers and NSAID-related dyspepsia. Recent comparative studies of PPIs versus H2 antagonists and misoprostol showed that, after 6-12 months of follow up, the proton pump inhibitors were significantly superior to control drugs in reducing the risk both of gastric and duodenal ulcer.

AB - While the most effective strategy to prevent non-steroidal anti-inflammatory drugs (NSAIDs) related gastrointestinal lesions, is to not prescribe them, this option is often impractical. The use of specific agents to prevent NSAIDs toxicity has focused upon two approaches: replacement of prostaglandin deficiency and inhibition of acid secretion. H2 blockers significantly reduce duodenal ulcer rates, but are ineffective in preventing gastric ulceration. In long term prevention studies, proton pump inhibitors have been shown to reduce the risk of gastric and duodenal ulcers and NSAID-related dyspepsia. Recent comparative studies of PPIs versus H2 antagonists and misoprostol showed that, after 6-12 months of follow up, the proton pump inhibitors were significantly superior to control drugs in reducing the risk both of gastric and duodenal ulcer.

KW - Gastro-duodenal ulcer

KW - H2 antagonists

KW - Misoprostol

KW - NSAIDs

KW - Proton pump inhibitors

UR - http://www.scopus.com/inward/record.url?scp=22544471854&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22544471854&partnerID=8YFLogxK

M3 - Articolo

VL - 18

SP - 39

EP - 45

JO - Argomenti di Gastroenterologia Clinica

JF - Argomenti di Gastroenterologia Clinica

SN - 1120-8651

IS - 1

ER -